Span Divergent, a company in the Pharmaceuticals industry, reported revenue of ₹5.41 crore and a net loss of ₹0.76 crore for the September 2026 quarter.
Span Divergent (BSE: SDL) closed at ₹27.00 on 18 Nov 2026, down 11.7% over the past year. Its market capitalisation is ₹20 crore.
Incorporated in 1972, Span Divergent Ltd deals in different businesses through various subsidiaries.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.